drugset

drugset / Trial / NCT00781534

A Clinical Trial of Ginseng in Diabetes

NCT00781534 ↗

Phase 0 Completed 19 enrolled Washington University School of Medicine

RandomizedParallel-groupQuadruple-blindBasic science

Summary

a clinical study of Ginseng its potential affect on diabetes

Timeline

Start: 2003-09
Primary completion: 2004-12
Completion: 2008-09

Publications

Reeds DN, Patterson BW, Okunade A, Holloszy JO, Polonsky KS, Klein S. Ginseng and ginsenoside Re do not improve beta-cell function or insulin sensitivity in overweight and obese subjects with impaired glucose tolerance or diabetes. Diabetes Care. 2011 May;34(5):1071-6. doi: 10.2337/dc10-2299. Epub 2011 Mar 16.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	American ginseng	Unknown	8 g	Oral
Comparator	ginsenoside RE	Unknown	250 mg	Oral
Comparator	ginsenoside RE	Unknown	500 mg	Oral

Indications